Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. OFEV® (nintedanib capsules), for oral use Initial U.S. Approval: 2014
Medication labelWhy this: Advisory · dailymed-prescription
OFEV is indicated for the treatment of adults with idiopathic pulmonary fibrosis (IPF). OFEV is indicated for the treatment of adults with chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype [see Clinical Studies (14.2)]. OFEV is indicated to slow the rate of decline in pulmonary function in adult patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD).
- generic_name
- nintedanib
- product_names
- nintedanib
- ndc
- 0597-0145, 0597-0145-60, 0597-0143, 0597-0143-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en